Target Discovery
Hit to Lead
Translational
Risk Bridge
De-risk finalist with deeper mechanistic panels and species-specific variants before full animal studies
Candidate Nomination
Preclinical In-Vivo
#192D5D
#284A8E
#255AAF
#2469A8
#2F88F2
#7ABBFC
#93CBF9
#B8DCF4
High Throughput Screening
Prospective
Toxicity Screens
Screen compounds in NAMkindTM Liver or Intestine Models to remove early liabilities
Lead Optimization
IND Enabling
Investigational
Toxicology
Use NAMkindTM models to uncover mechanisms, assess human relevance, and offer rescue strategies or a confident stop
Clinical Trials
Standard service timeline
Day -3 Seeding Liver Model
Day 0 1st Dosing
Days 1-7 2-3rd Repeat Dosing
Week 2 Experimentation Completed
Weeks 2-4 Data Analysis
Week 4 Data Output
